BIIB Filing
10-QFiling Date: Apr 29, 2026

BIOGEN INC. (BIIB) · Quarterly Report (10-Q) SEC Filing

biib-20260331

descriptionView SEC Filing
ACC: 0000875045-26-000045open_in_new
Key Financial Metrics3M Mar'26 · 2026-03-31
Revenue$2.48B
Net Income$319.5M
Total Assets$29.48B
Stockholders' Equity$20.87B
Operating Cash Flow$645.5M

keid AI analysis is for reference only and does not constitute investment advice.